BMT CTN Protocol 0804

Phase II Study of Reduced- Intensity Allogeneic Stem Cell Transplant For High Risk Chronic Lymphocytic Leukemia (CLL)

Below are protocol-related documents, which may be periodically updated.

            Protocol Chair: Richard T. Maziarz, MD (503-494-4606) maziarzr@ohsu.edu

            Protocol Officer: Mary Horowitz, MD marymh@mcw.edu

            Protocol Coordinator: Morgen Alexander-Young (773-834-4091)                       malexander-young@uchicago.edu

        

           

This study has reached its final accrual goal; the study closed to new patient accrual on January 27, 2014.